Filter
1131
Filtered Results: 1131
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
108
New Publications
284
Language
Document type
No document type
520
Studies & Reports
233
Guidelines
192
Manuals
79
Strategic & Response Plan
59
Fact sheets
20
Training Material
14
Situation Updates
8
Resource Platforms
3
Brochures
2
Infographics
1
Countries / Regions
Global
52
India
44
Kenya
40
Western and Central Europe
31
Ethiopia
30
Nigeria
25
South Africa
18
Ghana
17
Sierra Leone
15
Uganda
15
Zimbabwe
14
Bangladesh
14
Ukraine
14
Philippines
13
Nepal
13
Malawi
13
Zambia
12
Tanzania
12
Rwanda
12
Eastern Europe
12
Latin America and the Carribbean
11
Africa
11
Namibia
10
South–East Asia Region
10
Eswatini/ Swaziland
8
Eastern Europe and Central Asia
8
Liberia
7
Syria
7
Indonesia
7
Myanmar / Burma
7
Botswana
6
West and Central Africa
6
Thailand
5
East and Southern Africa
5
Senegal
4
Cambodia
4
Burkina Faso
3
USA
3
Haiti
3
Egypt
3
Middle East and North Africa
3
Western Pacific Region
3
Asia
3
Congo, Democratic Republic of
2
Cameroon
2
Jordan
2
Germany
2
Lebanon
2
Sudan
2
Benin
2
North Macedonia
2
Serbia
2
Lesotho
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
Vietnam
2
North America
2
Jamaica
2
United Kingdom
2
Guinea
1
Mali
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Afghanistan
1
China
1
Mozambique
1
Papua New Guinea
1
Libya
1
Madagascar
1
Chile
1
Fiji
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
383
Clinical Guidelines
107
Public Health
69
Key Resources
44
Women & Child Health
39
Pharmacy & Technologies
35
Capacity Building
9
Toolboxes
AMR
136
Pharmacy
133
COVID-19
81
TB
57
Mental Health
56
HIV
52
Rapid Response
48
Planetary Health
27
Caregiver
26
Global Health Education
25
Conflict
22
NCDs
22
NTDs
21
Health Financing Toolbox
16
Specific Hazards
12
Ebola
10
Polio
8
Disability
7
Refugee
7
Natural Hazards
4
Zika
2
Cholera
1
Social Ethics
1
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ...
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
Consultancy Report May 2022
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
Snakebite envenoming constitutes a serious medical condition that primarily affects residents of rural communities in Africa, Asia, Latin America, and New Guinea. It is an occupational, environmental, and domestic health hazard that exacerbates the already impoverished state of these communities. Co...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,...
